Procedure for Stability Testing of Large Molecule Drugs According to FDA Guidelines

1) Purpose

The purpose of this SOP is to define a procedure for conducting stability testing on large molecule drugs (biologics) in accordance with US FDA guidelines. This ensures that such drugs maintain their quality, safety, and efficacy throughout their shelf life.

2) Scope

This SOP applies to all personnel involved in the stability testing of large molecule drugs, including product development, quality control, and regulatory affairs teams.

3) Responsibilities

Biologics Development Team: Responsible for developing the biologic product and selecting appropriate packaging materials.
Stability Study Team: Responsible for conducting stability tests according to FDA guidelines.
Quality Assurance Team: Responsible for reviewing data for compliance with regulatory requirements.

4) Procedure

4.1 Protocol Development

4.1.1 Develop a stability testing protocol that aligns with FDA guidelines, considering the unique characteristics of large molecules such as proteins

“Ensuring Pharmaceutical Purity and Potency: Unveiling Effective Techniques for Reliable Stability Testing and Quality Control”

4.1.2 Include parameters such as potency, purity, and degradation products, along with storage conditions.

4.2 Sample Collection and Storage

4.2.1 Collect samples from representative batches of the biologic product.

4.2.2 Store samples under specified conditions (e.g., refrigerated, frozen) according to FDA recommendations.

4.3 Conducting Stability Tests

4.3.1 Perform tests at defined intervals (e.g., 0, 3, 6,